Lataa...
Lung Cancer with MET exon 14 Skipping Mutation: Genetic Feature, Current Treatments, and Future Challenges
MET exon 14 skipping mutation (MET∆ex14) is present about 3% of non-small cell lung cancers (NSCLCs). NSCLC patients with MET∆ex14 are characterized by an average age of over 70 years at diagnosis, a smoking history and a higher frequency in pleomorphic carcinoma and adenosquamous cell carcinoma tha...
Tallennettuna:
| Julkaisussa: | Lung Cancer (Auckl) |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8290191/ https://ncbi.nlm.nih.gov/pubmed/34295201 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S269307 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|